These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 2445259

  • 1. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum.
    Kish SJ, Shannak K, Hornykiewicz O.
    Ann Neurol; 1987 Sep; 22(3):386-9. PubMed ID: 2445259
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
    Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y.
    Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
    Martínez-Mir MI, Pollard H, Moreau J, Traiffort E, Ruat M, Schwartz JC, Palacios JM.
    Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088
    [Abstract] [Full Text] [Related]

  • 6. Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain.
    Walsh FX, Stevens TJ, Langlais PJ, Bird ED.
    Ann Neurol; 1982 Jul; 12(1):52-5. PubMed ID: 7114818
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F, Chalansonnet M, Carabin N, Micillino JC.
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M, Desmond TJ, Albin RL, Frey KA.
    Synapse; 2001 Sep 15; 41(4):329-36. PubMed ID: 11494403
    [Abstract] [Full Text] [Related]

  • 11. Aging and the nigrostriatal dopamine system: a non-human primate study.
    Irwin I, DeLanney LE, McNeill T, Chan P, Forno LS, Murphy GM, Di Monte DA, Sandy MS, Langston JW.
    Neurodegeneration; 1994 Dec 15; 3(4):251-65. PubMed ID: 7531106
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
    Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM.
    J Neurosci Methods; 2004 Dec 30; 140(1-2):169-81. PubMed ID: 15589347
    [Abstract] [Full Text] [Related]

  • 18. Unilateral destruction of dopamine pathways increases ipsilateral striatal serotonin turnover in rats.
    Karstaedt PJ, Kerasidis H, Pincus JH, Meloni R, Graham J, Gale K.
    Exp Neurol; 1994 Mar 30; 126(1):25-30. PubMed ID: 7512513
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.